Atossa Genetics (ATOS) Reports Q2 Loss of $0.11

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.11), versus ($0.13) reported last year. Revenue for the quarter came in at $2.69 million versus the consensus estimate of $9.9 thousand.

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
• RUM Group reports GPU use surge and $270M in contracted revenue
• Chip stocks hit record 19.7% of S&P 500, quadrupling since 2020